Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com.

Company Profile

1129 North McDowell Blvd.
Petaluma, California 94954

(Formerly Oculus Innovative Sciences)

(707) 283-0550

(707) 283-0551



Intraday stock chart for SNOA


James Schutz

Chief Executive Officer

Robert Miller

Chief Financial Officer

Bruce Thornton

Executive Vice President

Robert Northey Ph.D

Director of Research and Development

View Management Team

Past Six Months

6 month stock chart for SNOA

Investor Relations

Scott Gordon
President Core IR
377 Oak Street
Garden City, NY. 11530
Tel: 516-222-2560

Transfer Agent

Computershare Inc.
211 Quality Circle
Suite 210
College Station, TX. 77845
Tel: 201-680-6578


Marcum LLP
750 Third Ave
11th Floor
New York, NY. 10017
Tel: 212-485-5500

Corporate Counsel

Marlene Martin
Associate Attorney
Trombly Business Law, PC
1314 Main Street, Suite 102
Louisville, CO 80027
Office Phone (617) 243-0050
Fax (617) 243-0066

Subscribe to IR news and filing alerts

You can opt out at any time. We do not share or sell your info.